Showing results (1571-1580 of 2,038) with videos related to
Sort By:
Pageof 204
European Urology Oncology|March 3, 2023
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate CancerAli Sabbagh, Samuel L Washington, Derya Tilki, et al.European Urology Oncology|March 4, 2023
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission TomographyClayton P Smith, James A Proudfoot, Paul C Boutros, et al.Antiviral Research|November 14, 2024
Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral ResearchStephen R Welch, John P Bilello, Kara Carter, et al.NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.Nature Genetics|January 20, 2015
The landscape of long noncoding RNAs in the human transcriptomeMatthew K Iyer, Yashar S Niknafs, Rohit Malik, et al.Practical Radiation Oncology|January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifeWilliam C Jackson, Robert T Dess, Dale W Litzenberg, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Template switching by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravirAsif Rakib, Arnab Das, Subhas C Bera, et al.Journal of the Neurological Sciences|July 31, 2021
Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reportingBrandon E Turner, Christopher J Magnani, Alexander Frolov, et al.The Lancet. Oncology|December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1John R Prensner, Shuang Zhao, Nicholas Erho, et al.Pageof 204